NovaScan Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.08M

  • Investors
  • 13

NovaScan General Information

Description

Developer of a non-invasive virus detection platform designed for cancer detection and stratification. The company has active programs in skin, lung, GI, and breast cancer, and its technology can be used in minimally invasive procedures and can be used to dose therapeutics into live tumors, enabling physicians to improve patient outcomes, increase physician economics, and reduce the cost of care.

Contact Information

Formerly Known As
EPET
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 North Aberdeen
  • Suite 900
  • Chicago, IL 60642
  • United States
+1 (312)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • 400 North Aberdeen
  • Suite 900
  • Chicago, IL 60642
  • United States
+1 (312)

NovaScan Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NovaScan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 18-Aug-2026 $3.08M Completed Generating Revenue
13. Secondary Transaction - Private 01-Jun-2026 Completed Generating Revenue
12. Grant 21-Nov-2025 Completed Generating Revenue
11. Later Stage VC 29-Nov-2022 Completed Generating Revenue
10. Later Stage VC (Series B) 17-Nov-2021 Completed Generating Revenue
9. Later Stage VC 24-Jul-2017 Completed Generating Revenue
8. Grant 11-Aug-2016 Completed Generating Revenue
7. Accelerator/Incubator 10-Aug-2016 Completed Generating Revenue
6. Accelerator/Incubator $1.78M Completed Generating Revenue
5. Grant 04-Jan-2015 $2.3M $1.78M Completed Generating Revenue
To view NovaScan’s complete valuation and funding history, request access »

NovaScan Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
To view NovaScan’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NovaScan Patents

NovaScan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260140102-A1 Impedance measurement using bipolar configurations of electrodes Pending 15-Nov-2024
WO-2026106923-A1 Impedance measurement using bipolar configurations of electrodes Pending 15-Nov-2024
JP-2025539693-A Techniques for assessing cancer tissue during surgical biopsy Pending 14-Oct-2022
AU-2023361311-A1 Techniques for assessing cancerous tissue during surgical biopsies Active 14-Oct-2022
AU-2023361311-B2 Techniques for assessing cancerous tissue during surgical biopsies Active 14-Oct-2022 G01N33/4836
To view NovaScan’s complete patent history, request access »

NovaScan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NovaScan Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cancer Prevention and Research Institute of Texas Government
Aerion Capital Family Office
Portal Innovations Venture Capital Minority
BioPacific Investors Angel Group Minority
Builders VC Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

NovaScan FAQs

  • When was NovaScan founded?

    NovaScan was founded in 2003.

  • Where is NovaScan headquartered?

    NovaScan is headquartered in Chicago, IL.

  • What is the size of NovaScan?

    NovaScan has 16 total employees.

  • What industry is NovaScan in?

    NovaScan’s primary industry is Diagnostic Equipment.

  • Is NovaScan a private or public company?

    NovaScan is a Private company.

  • What is NovaScan’s current revenue?

    The current revenue for NovaScan is .

  • How much funding has NovaScan raised over time?

    NovaScan has raised $15.9M.

  • Who are NovaScan’s investors?

    Cancer Prevention and Research Institute of Texas, Aerion Capital, Portal Innovations, BioPacific Investors, and Builders VC are 5 of 13 investors who have invested in NovaScan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process